Oncostatin-M ligand-based CAR-T therapy displays robust anti-tumor activity against osteosarcoma
Favorite
Share
More Options
18

Open in WPS to view all 18 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
